FDA Drug Application (012813) for BLEPHAMIDE by ALLERGAN

Back to FDA Applications sponsored by ALLERGAN

Application Number012813
Product Number002
FormSUSPENSION;OPHTHALMIC
Dosage0.2%;10%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBLEPHAMIDE
Active IngredientPREDNISOLONE ACETATE; SULFACETAMIDE SODIUM

Active IngredientCount
List of drugs with Active Ingredient PREDNISOLONE ACETATE21
List of drugs with Active Ingredient SULFACETAMIDE SODIUM30


Back to FDA Applications sponsored by ALLERGAN